ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report
BACKGROUND Even though renal transplantation across blood groups is not uncommonly practiced nowadays, there is still hesitation regarding ABO-incompatible transplantation with very high baseline antibody titer. In this case report, the outcome of an ABO-incompatible kidney transplant recipient with...
Gespeichert in:
Veröffentlicht in: | The American journal of case reports 2017-10, Vol.18, p.1073-1076 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1076 |
---|---|
container_issue | |
container_start_page | 1073 |
container_title | The American journal of case reports |
container_volume | 18 |
creator | Ray, Deepak Shankar Thukral, Sharmila |
description | BACKGROUND Even though renal transplantation across blood groups is not uncommonly practiced nowadays, there is still hesitation regarding ABO-incompatible transplantation with very high baseline antibody titer. In this case report, the outcome of an ABO-incompatible kidney transplant recipient with a high baseline isoagglutinin titer is reported. CASE REPORT The patient was a non-diabetic, 33-year-old man with end-stage renal disease secondary to chronic glomerulonephritis. The only kidney donor available was his mother, who was blood-group incompatible. The patient's blood group was O positive, whereas his mother was B positive. We evaluated him for an ABO-incompatible renal transplant. The baseline anti-B isoagglutinin titer was >1:8196. With a desensitization protocol of low-dose Rituximab, plasmapheresis, and IVIG, this titer was brought down to 1:32 before transplantation. He successfully underwent renal transplantation across the ABO barrier, and maintains good graft function after 1 year of follow-up. CONCLUSIONS In the present era, a high baseline isoagglutinin titer is no longer a contraindication for successful kidney transplantation in ABO-incompatible recipient-donor pairs. |
doi_str_mv | 10.12659/AJCR.905633 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5642648</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1948753064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-1eedb84eb03bbc6de10e61f2a00807182f99aebb7fb15d164d6d4f76358b1e93</originalsourceid><addsrcrecordid>eNpVkcFPgzAUxhujccvczbPh6EFmS6EUDyZI1M0sLlm4Ny08NgxQbJlm_73MzWW-S19ef_3e6_sQuiZ4QjwWRPfxW7KcRDhglJ6hIYl84gaRR89P8gEaW_uB-2AeCz16iQYejzjFIR2i9_hp4c6aTNet7EpVgbOERlZOamRj20o2XV_WjfNddmtnWq7WTtz0nM63Tlp2YB6c2Emk3T1rtemu0EUhKwvjwzlC6ctzmkzd-eJ1lsRzN6Pc71wCkCvug8JUqYzlQDAwUngSY45Dwr0iiiQoFRaKBDlhfs5yvwgZDbgiENERetzLthtVQ55B0xlZidaUtTRboWUp_t805Vqs9JcImO8xn_cCtwcBoz83YDtRlzaDqv8w6I0V_fJ4GFDM_B6926OZ0dYaKI5tCBa_JoidCWJvQo_fnI52hP9WTn8AjuGCng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1948753064</pqid></control><display><type>article</type><title>ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Ray, Deepak Shankar ; Thukral, Sharmila</creator><creatorcontrib>Ray, Deepak Shankar ; Thukral, Sharmila</creatorcontrib><description>BACKGROUND Even though renal transplantation across blood groups is not uncommonly practiced nowadays, there is still hesitation regarding ABO-incompatible transplantation with very high baseline antibody titer. In this case report, the outcome of an ABO-incompatible kidney transplant recipient with a high baseline isoagglutinin titer is reported. CASE REPORT The patient was a non-diabetic, 33-year-old man with end-stage renal disease secondary to chronic glomerulonephritis. The only kidney donor available was his mother, who was blood-group incompatible. The patient's blood group was O positive, whereas his mother was B positive. We evaluated him for an ABO-incompatible renal transplant. The baseline anti-B isoagglutinin titer was >1:8196. With a desensitization protocol of low-dose Rituximab, plasmapheresis, and IVIG, this titer was brought down to 1:32 before transplantation. He successfully underwent renal transplantation across the ABO barrier, and maintains good graft function after 1 year of follow-up. CONCLUSIONS In the present era, a high baseline isoagglutinin titer is no longer a contraindication for successful kidney transplantation in ABO-incompatible recipient-donor pairs.</description><identifier>ISSN: 1941-5923</identifier><identifier>EISSN: 1941-5923</identifier><identifier>DOI: 10.12659/AJCR.905633</identifier><identifier>PMID: 28983073</identifier><language>eng</language><publisher>United States: International Scientific Literature, Inc</publisher><subject>ABO Blood-Group System ; Adult ; Blood Group Incompatibility ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Immunologic Factors - therapeutic use ; Kidney Transplantation ; Living Donors ; Male ; Plasmapheresis ; Rituximab - therapeutic use ; Transplantation Conditioning - methods</subject><ispartof>The American journal of case reports, 2017-10, Vol.18, p.1073-1076</ispartof><rights>Am J Case Rep, 2017 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-1eedb84eb03bbc6de10e61f2a00807182f99aebb7fb15d164d6d4f76358b1e93</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642648/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642648/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28983073$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ray, Deepak Shankar</creatorcontrib><creatorcontrib>Thukral, Sharmila</creatorcontrib><title>ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report</title><title>The American journal of case reports</title><addtitle>Am J Case Rep</addtitle><description>BACKGROUND Even though renal transplantation across blood groups is not uncommonly practiced nowadays, there is still hesitation regarding ABO-incompatible transplantation with very high baseline antibody titer. In this case report, the outcome of an ABO-incompatible kidney transplant recipient with a high baseline isoagglutinin titer is reported. CASE REPORT The patient was a non-diabetic, 33-year-old man with end-stage renal disease secondary to chronic glomerulonephritis. The only kidney donor available was his mother, who was blood-group incompatible. The patient's blood group was O positive, whereas his mother was B positive. We evaluated him for an ABO-incompatible renal transplant. The baseline anti-B isoagglutinin titer was >1:8196. With a desensitization protocol of low-dose Rituximab, plasmapheresis, and IVIG, this titer was brought down to 1:32 before transplantation. He successfully underwent renal transplantation across the ABO barrier, and maintains good graft function after 1 year of follow-up. CONCLUSIONS In the present era, a high baseline isoagglutinin titer is no longer a contraindication for successful kidney transplantation in ABO-incompatible recipient-donor pairs.</description><subject>ABO Blood-Group System</subject><subject>Adult</subject><subject>Blood Group Incompatibility</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Kidney Transplantation</subject><subject>Living Donors</subject><subject>Male</subject><subject>Plasmapheresis</subject><subject>Rituximab - therapeutic use</subject><subject>Transplantation Conditioning - methods</subject><issn>1941-5923</issn><issn>1941-5923</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkcFPgzAUxhujccvczbPh6EFmS6EUDyZI1M0sLlm4Ny08NgxQbJlm_73MzWW-S19ef_3e6_sQuiZ4QjwWRPfxW7KcRDhglJ6hIYl84gaRR89P8gEaW_uB-2AeCz16iQYejzjFIR2i9_hp4c6aTNet7EpVgbOERlZOamRj20o2XV_WjfNddmtnWq7WTtz0nM63Tlp2YB6c2Emk3T1rtemu0EUhKwvjwzlC6ctzmkzd-eJ1lsRzN6Pc71wCkCvug8JUqYzlQDAwUngSY45Dwr0iiiQoFRaKBDlhfs5yvwgZDbgiENERetzLthtVQ55B0xlZidaUtTRboWUp_t805Vqs9JcImO8xn_cCtwcBoz83YDtRlzaDqv8w6I0V_fJ4GFDM_B6926OZ0dYaKI5tCBa_JoidCWJvQo_fnI52hP9WTn8AjuGCng</recordid><startdate>20171006</startdate><enddate>20171006</enddate><creator>Ray, Deepak Shankar</creator><creator>Thukral, Sharmila</creator><general>International Scientific Literature, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171006</creationdate><title>ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report</title><author>Ray, Deepak Shankar ; Thukral, Sharmila</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-1eedb84eb03bbc6de10e61f2a00807182f99aebb7fb15d164d6d4f76358b1e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>ABO Blood-Group System</topic><topic>Adult</topic><topic>Blood Group Incompatibility</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Kidney Transplantation</topic><topic>Living Donors</topic><topic>Male</topic><topic>Plasmapheresis</topic><topic>Rituximab - therapeutic use</topic><topic>Transplantation Conditioning - methods</topic><toplevel>online_resources</toplevel><creatorcontrib>Ray, Deepak Shankar</creatorcontrib><creatorcontrib>Thukral, Sharmila</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ray, Deepak Shankar</au><au>Thukral, Sharmila</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report</atitle><jtitle>The American journal of case reports</jtitle><addtitle>Am J Case Rep</addtitle><date>2017-10-06</date><risdate>2017</risdate><volume>18</volume><spage>1073</spage><epage>1076</epage><pages>1073-1076</pages><issn>1941-5923</issn><eissn>1941-5923</eissn><abstract>BACKGROUND Even though renal transplantation across blood groups is not uncommonly practiced nowadays, there is still hesitation regarding ABO-incompatible transplantation with very high baseline antibody titer. In this case report, the outcome of an ABO-incompatible kidney transplant recipient with a high baseline isoagglutinin titer is reported. CASE REPORT The patient was a non-diabetic, 33-year-old man with end-stage renal disease secondary to chronic glomerulonephritis. The only kidney donor available was his mother, who was blood-group incompatible. The patient's blood group was O positive, whereas his mother was B positive. We evaluated him for an ABO-incompatible renal transplant. The baseline anti-B isoagglutinin titer was >1:8196. With a desensitization protocol of low-dose Rituximab, plasmapheresis, and IVIG, this titer was brought down to 1:32 before transplantation. He successfully underwent renal transplantation across the ABO barrier, and maintains good graft function after 1 year of follow-up. CONCLUSIONS In the present era, a high baseline isoagglutinin titer is no longer a contraindication for successful kidney transplantation in ABO-incompatible recipient-donor pairs.</abstract><cop>United States</cop><pub>International Scientific Literature, Inc</pub><pmid>28983073</pmid><doi>10.12659/AJCR.905633</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1941-5923 |
ispartof | The American journal of case reports, 2017-10, Vol.18, p.1073-1076 |
issn | 1941-5923 1941-5923 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5642648 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | ABO Blood-Group System Adult Blood Group Incompatibility Humans Immunoglobulins, Intravenous - therapeutic use Immunologic Factors - therapeutic use Kidney Transplantation Living Donors Male Plasmapheresis Rituximab - therapeutic use Transplantation Conditioning - methods |
title | ABO-Incompatible Renal Transplantation with High Antibody Titer: A Case Report |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A11%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ABO-Incompatible%20Renal%20Transplantation%20with%20High%20Antibody%20Titer:%20A%20Case%20Report&rft.jtitle=The%20American%20journal%20of%20case%20reports&rft.au=Ray,%20Deepak%20Shankar&rft.date=2017-10-06&rft.volume=18&rft.spage=1073&rft.epage=1076&rft.pages=1073-1076&rft.issn=1941-5923&rft.eissn=1941-5923&rft_id=info:doi/10.12659/AJCR.905633&rft_dat=%3Cproquest_pubme%3E1948753064%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1948753064&rft_id=info:pmid/28983073&rfr_iscdi=true |